Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Overview of attention for article published in JAMA Ophthalmology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 4,526)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 55 news outlets
blogs: 3 blogs
twitter: 38 X users
reddit: 3 Redditors

video: 1 YouTube creator
guideline: 1 clinical guideline source
podcasts: 6 podcasts

Readers on

mendeley: 93 Mendeley

So far, Altmetric has seen 3 posts from 3 blogs.

VUMC participates in national study to test eye drops for nearsightedness in children

VUMC News, 01 Aug 2023

by Nancy…

RCT | No significant impact of low-dose 0.01% atropine on myopia progression in children

SPECIALTIES, 25 Jul 2023

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial – JAMA Ophthalmology (link to…

Atropine 0.01 Percent Eye Drops Do Not Slow Myopia Progression

Physician's Weekly, 18 Jul 2023

MONDAY, July 17, 2023 (HealthDay News) — For children aged 5 to 12 years with low-to-moderate bilateral myopia, atropine 0.01…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.